Spiperone
![Selective Labeling of Serotonin Receptors Byd-[3H]Lysergic Acid](http://data.docslib.org/img/264x/05ff5f51e0de2cd7b4a3c03bbc1707cd.webp)
Top View
- Binding Kinetics of Cariprazine and Aripiprazole at the Dopamine D3 Receptor Received: 17 May 2018 Annika Frank1, Dóra J
- (2006.01) A61P 25/36 (2006.01) A61K 9/00 (2006.01) (21) International Application Number: PCT/US20 19/059852 (22) International Filing Date: 05 November 2019 (05
- Distinct Dopamine D2 Receptor Antagonists Differentially Impact D2 Receptor Oligomerization
- D2 Receptor Occupancy During High- and Low- Dose Therapy with the Atypical Antipsychotic Amisulpride: a 123I-Iodobenzamide SPECT Study
- Drugs and Devices to Prevent Migraines in Adults
- Psychotropic Drugs Show Anticancer Activity by Disrupting Mitochondrial and Lysosomal Function
- Catecholamine Receptor Binding in Rat Kidney: Effect of Aging
- Aripiprazole, a Novel Antipsychotic Agent : Dopamine D Receptor Partial
- Supplementary Materials
- High Affinity Dopamine D2 Receptor Radioligands. 1. Regional Rat Brain Distribution of Iodinated Benzamides
- In Vitro Screening of a FDA Approved Chemical Library Reveals Potential Inhibitors
- Spiperone: Evidence for Uptake Into Secretory Granules (Pituitary/Prolactin/Biogenic Amine/Reserpine) PRISCILLA S
- Mining of High Throughput Screening Database Reveals AP-1 And
- In the Kidney Inner Medulla (Prostaglandin E2/Collecting Duct) T
- Inhibitory Effects of Antipsychotics on the Contractile Response To
- Distinct Inactive Conformations of the Dopamine D2 and D3 Receptors
- Developmental Pattern of 3H-Spiperone Binding Sites in Rat Brain
- Dopamine D2 and D3 Receptor Occupancy